Understand the source comparison
Using KPV for Gut Health Research Evidence: Model Comparison
DSS-Induced Colitis (Mouse) Epithelial barrier disruption → innate immune activation 5–10 mg/kg IP daily High. Multiple independent replications, consistent DAI reduction Strong for ulcerative colitis modeling; limited for Crohn's transmural pathology Best-val
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- DSS-Induced Colitis (Mouse)
- Epithelial barrier disruption → innate immune activation
- 5–10 mg/kg IP daily
- High. Multiple independent replications, consistent DAI reduction
- Strong for ulcerative colitis modeling; limited for Crohn's transmural pathology
- Best-validated model for KPV gut research. Reproducible outcomes across institutions
- TNBS Colitis (Rat)
- Th1-mediated transmural inflammation
- 5–7.5 mg/kg IP or oral
- Moderate. Fewer studies, variable histological scoring methods
- Relevant for Crohn's disease pathology; sustained anti-inflammatory effects demonstrated
- Useful for Crohn's-like inflammation investigation; requires standardized histology protocols
- Human Colonic Biopsy Ex Vivo
- Patient-specific cytokine profiles
- 25–100 μM in culture medium
- Moderate. Small sample sizes, high inter-patient variability
- Highest translational value. Direct human tissue response data
- Most clinically relevant but requires fresh biopsy access and rapid processing
- Caco-2 Monolayer (In Vitro)
- NF-κB pathway activation via TNF-α or LPS
- 10–100 μM depending on barrier integrity
- High. Mechanistic clarity, reproducible cytokine/permeability outcomes
- Limited. Lacks immune cell interactions and microbiome factors
- Gold standard for mechanistic studies; essential for dose-finding before animal work